Research Paper Volume 14, Issue 22 pp 9128—9148
Prognostic value and immunological role of FOXM1 in human solid tumors
Figure 9. Validation of the immunotherapeutic predictive value of FOXM1. (A) Kaplan–Meier OS curves for patients with FOXM1 high and low expression subgroups in IMvigor 210 cohort. (B) FOXM1 expression was higher in responders than that in non-responders. (C) The proportion of patients with response to anti- PD-L1 therapy in FOXM1 high and low expression groups. p < 0.05 was considered significant.